EUVIMEDEUVIMED entdecken
Crossref

The Development of Novel Antimalarial Drugs

Dr. David Smith

American Journal Of Pharmacy And Pharmacology · 31.10.2024 · 5 (5) · 5-8

DOI: 10.71465/ajpp.3362 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 31.10.2024. Verfasst von Dr. David Smith.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria remains a major global health challenge, particularly in tropical and subtropical regions. The emergence of drug-resistant Plasmodium species has rendered many first-line antimalarial therapies less effective, highlighting the urgent need for new drugs. This article discusses recent advances in the development of novel antimalarial agents, including new chemical entities, repurposed drugs, and innovative delivery systems. It also explores the mechanisms of resistance, targets for drug development, and the future landscape of antimalarial pharmacotherapy.

Zitieren

APA

Smith, D. D. (2024). The Development of Novel Antimalarial Drugs. American Journal Of Pharmacy And Pharmacology, 5(5), 5-8. https://doi.org/10.71465/ajpp.3362

Vancouver

Smith DD. The Development of Novel Antimalarial Drugs. American Journal Of Pharmacy And Pharmacology. 2024;5(5):5-8. doi:10.71465/ajpp.3362

BibTeX
@article{Smith2024,
  author = {Smith, Dr. David},
  title = {The Development of Novel Antimalarial Drugs},
  journal = {American Journal Of Pharmacy And Pharmacology},
  year = {2024},
  volume = {5},
  number = {5},
  pages = {5--8},
  doi = {10.71465/ajpp.3362}
}
Kostenlos starten →